Chemed Corporation (NYSE:CHE - Get Free Report)'s share price hit a new 52-week low during trading on Monday . The company traded as low as $468.30 and last traded at $472.44, with a volume of 6237 shares traded. The stock had previously closed at $473.18.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the company. Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Bank of America decreased their price objective on Chemed from $708.00 to $650.00 and set a "buy" rating on the stock in a research note on Monday, June 30th. Finally, Royal Bank Of Canada restated an "outperform" rating and set a $640.00 target price (down from $674.00) on shares of Chemed in a research report on Monday, June 30th.
Check Out Our Latest Research Report on CHE
Chemed Trading Down 1.1%
The business has a fifty day moving average price of $549.12 and a 200-day moving average price of $561.45. The stock has a market capitalization of $6.82 billion, a PE ratio of 22.71, a PEG ratio of 2.24 and a beta of 0.50.
Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating analysts' consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The business had revenue of $646.94 million during the quarter, compared to analyst estimates of $641.78 million. During the same quarter in the prior year, the company posted $5.20 EPS. Chemed's quarterly revenue was up 9.8% compared to the same quarter last year. On average, equities analysts anticipate that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.
Chemed Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.43%. The ex-dividend date was Thursday, May 29th. Chemed's dividend payout ratio is currently 9.74%.
Insider Activity at Chemed
In other news, EVP Spencer S. Lee sold 1,500 shares of the stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the completion of the transaction, the executive vice president owned 14,627 shares of the company's stock, valued at approximately $8,454,259.73. This represents a 9.30% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 1,500 shares of the stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $576.45, for a total value of $864,675.00. Following the completion of the transaction, the chief executive officer directly owned 101,197 shares of the company's stock, valued at $58,335,010.65. This represents a 1.46% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 4,500 shares of company stock valued at $2,598,450 in the last three months. Corporate insiders own 3.29% of the company's stock.
Institutional Trading of Chemed
Several institutional investors have recently added to or reduced their stakes in CHE. Atala Financial Inc purchased a new stake in Chemed during the 4th quarter valued at $29,000. Alpine Bank Wealth Management purchased a new stake in Chemed during the 1st quarter valued at $29,000. CBIZ Investment Advisory Services LLC boosted its stake in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the last quarter. HM Payson & Co. purchased a new stake in Chemed during the 1st quarter valued at $30,000. Finally, SVB Wealth LLC purchased a new stake in Chemed during the 1st quarter valued at $30,000. 95.85% of the stock is currently owned by hedge funds and other institutional investors.
About Chemed
(
Get Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories
Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
